Back
Cellectar Biosciences, Inc. 10K Form
Sell
8
CLRB
Cellectar Biosciences, Inc.
Last Price:
$2.54
Seasonality Move:
-3.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLRB News And Ratings
See the #1 stock for the next 7 days that we like better than CLRB
CLRB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.89 |
| Price / Book: | 1.37 |
Profitability
| EPS (TTM): | -6.18380 |
|---|---|
| Net Income (TTM): | $-21.8M |
| Gross Margin: | $-213.6K |
| Return on Equity: | -209.22% |
| Return on Assets: | -128.46% |
Cellectar Biosciences, Inc. Earnings Forecast
Key Cellectar Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 24 years have been positive in 16 years.
Cellectar Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLRB |
| CUSIP: | 15117F |
| Website: | cellectar.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 2.96 |
| Quick Ratio: | 2.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLRB Technical Analysis vs Fundamental Analysis
Sell
8
Cellectar Biosciences, Inc. (CLRB)
is a Sell
Is Cellectar Biosciences, Inc. a Buy or a Sell?
-
Cellectar Biosciences, Inc. stock is rated a SellThe current Cellectar Biosciences, Inc. [CLRB] share price is $2.55. The Score for CLRB is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.